<DOC>
	<DOCNO>NCT02021019</DOCNO>
	<brief_summary>Sympathetic activation hallmark end-stage renal disease adversely affect cardiovascular prognosis . Hypertension present vast majority patient play key role progressive deterioration renal function exceedingly high rate cardiovascular event . Selective catheter-based renal denervation show safe effective attain improve sustained blood pressure control patient resistant hypertension normal renal function . The investigator hypothesize catheter-based renal denervation safe effective intervention achieve sustain reduction sympathetic nerve activity , BP target organ damage hypertensive End-Stage Renal Disease ( ESRD ) patient , result improve cardiovascular outcome .</brief_summary>
	<brief_title>Renal Denervation Improve Outcomes Patients With End-stage Renal Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>end stage renal disease hypertension ( BPâ‰¥140/90mmHg ) Individual renal artery anatomy ineligible treatment assess interventionalist . Individual experience myocardial infarction , unstable angina , cerebrovascular accident within 3 month screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>